Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CLPP: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Gene Symbol | CLPP |
| Full Name | Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit |
| Aliases | Caseinolytic Mitochondrial Matrix Peptidase Proteolytic |
| Chromosome | 19p13.3 |
| Protein Type | Protease |
| Molecular Weight | 23.4 kDa |
| Amino Acids | 473 aa |
| Pathways | Mitochondrial Proteostasis |
| UniProt ID | [Q9NZJ5](https://www.uniprot.org/uniprot/Q9NZJ5) |
| Ensembl ID | ENSG00000139289 |
| GeneCards | CLPP |
| Human Protein Atlas | CLPP |
| Heptad repeat regions | Oligomerization domains |
| Associated Diseases | Aging, Als, Ataxia, frontotemporal dementia, Ftd, Ms |
| Interactions | Akt, AKT, CHCHD2, DNM1L, DRP1, FBXO7 |
| KG Connections | 235 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
CLPP["CLPP"]
CLPP -->|"target for"| Neurodegeneration["Neurodegeneration"]
CLPP -->|"target for"| Aging["Aging"]
CLPP -->|"target for"| Ms["Ms"]
CLPP -->|"transports"| ALS["ALS"]
CLPP -->|"target for"| RAB11["RAB11"]
CLPP -->|"target for"| STX17["STX17"]
CLPP -->|"target for"| RAB5["RAB5"]
CLPP -->|"target for"| SNAP29["SNAP29"]
CLPP -->|"target for"| IGF2BP1["IGF2BP1"]
CLPP -->|"target for"| BDNF["BDNF"]
ELAVL2["ELAVL2"] -->|"target for"| CLPP
C1Q["C1Q"] -->|"target for"| CLPP
MTOR["MTOR"] -->|"target for"| CLPP
PI3K["PI3K"] -->|"target for"| CLPP
AUTOPHAGY["AUTOPHAGY"] -->|"target for"| CLPP
SNAP29 -->|"target for"| CLPP
IGF2BP1 -->|"target for"| CLPP
FUS["FUS"] -->|"target for"| CLPP
AKT["AKT"] -->|"target for"| CLPP
BDNF -->|"target for"| CLPP| Target | Relation | Type | Str |
|---|---|---|---|
| Mitochondrial Proteostasis | involved_in | process | 0.85 |
| Proteostasis | involved_in | process | 0.85 |
| mitochondrial protein degradation | mediates | process | 0.85 |
| Als | associated_with | disease | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| ALS | transports | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Neurodegeneration | encodes | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Als | transports | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Ftd | associated_with | disease | 0.65 |
| Ataxia | associated_with | disease | 0.65 |
| Aging | encodes | disease | 0.65 |
| Rb | therapeutic_target | protein | 0.60 |
| PIK3CA | therapeutic_target | gene | 0.60 |
| Rb | causes | protein | 0.60 |
| RAB5 | therapeutic_target | gene | 0.60 |
| ELAVL2 | therapeutic_target | gene | 0.60 |
| ATM | associated_with | gene | 0.60 |
| LARS2 | associated_with | gene | 0.60 |
| BDNF | therapeutic_target | gene | 0.60 |
| POLG | associated_with | gene | 0.60 |
| FUS | therapeutic_target | gene | 0.60 |
| SIL1 | associated_with | gene | 0.60 |
| Sumo | therapeutic_target | protein | 0.60 |
| ELAVL2 | associated_with | gene | 0.60 |
| SETX | associated_with | gene | 0.60 |
| RAB11 | therapeutic_target | gene | 0.60 |
| RAB11 | associated_with | gene | 0.60 |
| RAB5 | associated_with | gene | 0.60 |
| AKT | therapeutic_target | gene | 0.60 |
| MTOR | associated_with | gene | 0.60 |
| C1Q/C3 | associated_with | gene | 0.60 |
| TDP-43 | associated_with | gene | 0.60 |
| BDNF | associated_with | gene | 0.60 |
| LONP1 | transports | gene | 0.60 |
| PI3K | associated_with | gene | 0.60 |
| TDP-43 | therapeutic_target | gene | 0.60 |
| PIK3CA | activates | gene | 0.60 |
| DRD2 | associated_with | gene | 0.60 |
| TP53 | activates | gene | 0.60 |
| C1Q | therapeutic_target | gene | 0.60 |
| HARS | associated_with | gene | 0.60 |
| WFS1 | associated_with | gene | 0.60 |
| IGF2BP1 | therapeutic_target | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ELAVL2 | therapeutic_target | gene | 0.60 |
| C1Q | therapeutic_target | gene | 0.60 |
| MTOR | therapeutic_target | gene | 0.60 |
| AKT | associated_with | gene | 0.60 |
| BDNF | associated_with | gene | 0.60 |
| RAB5 | therapeutic_target | gene | 0.60 |
| BDNF | therapeutic_target | gene | 0.60 |
| PI3K | therapeutic_target | gene | 0.60 |
| SNAP29 | therapeutic_target | gene | 0.60 |
| IGF2BP1 | therapeutic_target | gene | 0.60 |
| FUS | therapeutic_target | gene | 0.60 |
| AKT | therapeutic_target | gene | 0.60 |
| LONP1 | associated_with | gene | 0.60 |
| STX17 | therapeutic_target | gene | 0.60 |
| WFS1 | associated_with | gene | 0.60 |
| HARS | associated_with | gene | 0.60 |
| ATM | associated_with | gene | 0.60 |
| MTOR | associated_with | gene | 0.60 |
| FUS | associated_with | gene | 0.60 |
| RAB5 | associated_with | gene | 0.60 |
| C1Q/C3 | associated_with | gene | 0.60 |
| RAB11 | associated_with | gene | 0.60 |
| PI3K | associated_with | gene | 0.60 |
| STX17 | associated_with | gene | 0.60 |
| IGF2BP1 | associated_with | gene | 0.60 |
| ELAVL2 | associated_with | gene | 0.60 |
| SNAP29 | associated_with | gene | 0.60 |
| LONP1 | transports | gene | 0.60 |
| C1Q | associated_with | gene | 0.60 |
| RAB11 | therapeutic_target | gene | 0.60 |
| C1Q/C3 | therapeutic_target | gene | 0.60 |
| ALS | associated_with | gene | 0.60 |
| YTHDF1 | therapeutic_target | gene | 0.60 |
| METTL3 | therapeutic_target | gene | 0.60 |
| AGING | therapeutic_target | gene | 0.60 |
| LYSOSOME | associated_with | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | associated_with | gene | 0.60 |
| ALS | transports | gene | 0.60 |
| NEURODEGENERATION | associated_with | gene | 0.60 |
| COMPLEMENT | associated_with | gene | 0.60 |
| AGING | associated_with | gene | 0.60 |
| AUTOPHAGY | therapeutic_target | gene | 0.60 |
| TP53 MUTATIONS | activates | gene | 0.60 |
| TP53 | activates | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| PIK3CA | activates | gene | 0.60 |
| DRD2 | associated_with | gene | 0.60 |
| ELAVL2 | encodes | gene | 0.60 |
| SNAP29 | encodes | gene | 0.60 |
| FUS | encodes | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning CLPP in their description or question text
No additional research found